These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 18579783)

  • 1. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
    Plouffe D; Brinker A; McNamara C; Henson K; Kato N; Kuhen K; Nagle A; Adrián F; Matzen JT; Anderson P; Nam TG; Gray NS; Chatterjee A; Janes J; Yan SF; Trager R; Caldwell JS; Schultz PG; Zhou Y; Winzeler EA
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9059-64. PubMed ID: 18579783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials.
    Brobey RK; Sano G; Itoh F; Aso K; Kimura M; Mitamura T; Horii T
    Mol Biochem Parasitol; 1996 Oct; 81(2):225-37. PubMed ID: 8898337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for antifolate action and resistance in malaria.
    Yuthavong Y
    Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
    Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
    ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
    Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors.
    Adane L; Bharatam PV
    Curr Med Chem; 2008; 15(16):1552-69. PubMed ID: 18673224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs.
    Hyde JE
    Microbes Infect; 2002 Feb; 4(2):165-74. PubMed ID: 11880048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for new antimalarial therapeutics amongst known drugs.
    Weisman JL; Liou AP; Shelat AA; Cohen FE; Guy RK; DeRisi JL
    Chem Biol Drug Des; 2006 Jun; 67(6):409-16. PubMed ID: 16882315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
    Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
    Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical genetics of Plasmodium falciparum.
    Guiguemde WA; Shelat AA; Bouck D; Duffy S; Crowther GJ; Davis PH; Smithson DC; Connelly M; Clark J; Zhu F; Jiménez-Díaz MB; Martinez MS; Wilson EB; Tripathi AK; Gut J; Sharlow ER; Bathurst I; El Mazouni F; Fowble JW; Forquer I; McGinley PL; Castro S; Angulo-Barturen I; Ferrer S; Rosenthal PJ; Derisi JL; Sullivan DJ; Lazo JS; Roos DS; Riscoe MK; Phillips MA; Rathod PK; Van Voorhis WC; Avery VM; Guy RK
    Nature; 2010 May; 465(7296):311-5. PubMed ID: 20485428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum: Multidrug resistance.
    Rout S; Mahapatra RK
    Chem Biol Drug Des; 2019 May; 93(5):737-759. PubMed ID: 30663249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target identification and validation of novel antimalarials.
    McNamara C; Winzeler EA
    Future Microbiol; 2011 Jun; 6(6):693-704. PubMed ID: 21707315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular approaches to the spreading problem of drug resistant malaria.
    Plowe CV; Wellems TE
    Adv Exp Med Biol; 1995; 390():197-209. PubMed ID: 8718614
    [No Abstract]   [Full Text] [Related]  

  • 18. Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen.
    Tanaka TQ; Guiguemde WA; Barnett DS; Maron MI; Min J; Connelly MC; Suryadevara PK; Guy RK; Williamson KC
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1389-97. PubMed ID: 25512421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Hydrophobic aromatic substituent pyrimethamine analogues as potential antimalarials for pyrimethamine-resistant Plasmodium falciparum.
    Saepua S; Sadorn K; Vanichtanankul J; Anukunwithaya T; Rattanajak R; Vitsupakorn D; Kamchonwongpaisan S; Yuthavong Y; Thongpanchang C
    Bioorg Med Chem; 2019 Dec; 27(24):115158. PubMed ID: 31685330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
    Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
    Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.